Cancer Epigenetic Insights: Molecular intricacies of TET3 Gene Diagnostic and Its Therapeutics in Breast Cancer Subtypes and Progression
Year: 2024
Type: article
Study design: Observational Study
Abstract: Breast Cancer has become the predominant neoplasm affecting women’s healthy globally. Many evidences interlink TET3 gene with breast cancer. The purpose of this study is to investigate the diagnostic and therapeutic potential of TET3 gene expression in breast cancer subtypes. After study approval (CIIT-FA22-RBM/006/ISB) breast cancer tissue samples were obtained, total RNA was extracted and reverse transcription was done. Specific PCR primers for TET3 were designed to minimize mis-amplification. For validation, Relative real time PCR was used to see the expression profile of TET3 in different subtypes of breast cancer. The analysis showed that the variability in the level of TET3 gene was present between various types of breast cancer. Specifically, high or low TET3 level presented with some degree of correlation to tumor progression proving TET3 as a molecular biomarker. Findings emphasized that TET3 gene expression can be a potential diagnostic and therapeutic target in breast cancer. Dysregulation of miR-214 implicates potential utility as a biomarker of disease progression and specific adopted therapies.
Authors: Muqadas Fatima, Ayisha Yousaf, Khadija Riaz, Arfa Ijaz, Nimra Asghar, Muhammad Saeed
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4405792011
